NT79: A Novel Neurotensin Receptor Agonist with Selective Behavioral Effects

被引：0
|
作者：
Boules, Mona M. [1 ]
Liang, Yanqi [1 ]
Oliveros, Alfredo [1 ]
Fauq, Irfan [1 ]
Wilson, Mina [1 ]
Khaniyev, Shaheen [1 ]
Williams, Katrina [1 ]
Barbut, Denise [2 ]
Richelson, Elliott [1 ]
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
[2] Sarentis Therapeut Inc, Res, New York, NY USA
来源：
BIOLOGICAL PSYCHIATRY | 2009年 / 65卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
232
引用
收藏
页码：71S / 71S
页数：1
相关论文
共 50 条
  • [1] NT79: A novel neurotensin analog with selective behavioral effects
    Boules, Mona
    Liang, Yanqi
    Briody, Siobhan
    Miura, Tomofumi
    Fauq, Irfan
    Oliveros, Alfredo
    Wilson, Mina
    Khaniyev, Shaheen
    Williams, Katrina
    Li, Zhimin
    Qi, Yanfei
    Katovich, Michael
    Richelson, Elliott
    BRAIN RESEARCH, 2010, 1308 : 35 - 46
  • [2] Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine
    Boules, Mona
    Johnston, Hannah
    Tozy, Jessica
    Smith, Kristin
    Li, Zhimin
    Richelson, Elliott
    BEHAVIOURAL PHARMACOLOGY, 2011, 22 (5-6): : 573 - 581
  • [3] Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys
    Fantegrossi, WE
    Ko, MCH
    Woods, JH
    Richelson, E
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 80 (02) : 341 - 349
  • [4] NT69L: A neurotensin receptor agonist for treatment of neuropsychiatric diseases
    Richelson, E
    Boules, M
    Fredrickson, P
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S50 - S50
  • [5] Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: Lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice
    Mechanic, Jordan A.
    Sutton, Janette E.
    Berson, Amy E.
    Wu, Xiaosu
    Kwan, Joyce
    Schreiber, Rudy
    Pang, Zhen
    Button, Donald C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (07) : 466 - 475
  • [6] Antipsychotic-like effects of a neurotensin receptor type 1 agonist
    Vadnie, Chelsea A.
    Ayers-Ringler, Jennifer
    Oliveros, Alfredo
    Abulseoud, Osama A.
    Choi, Sun
    Hitschfeld, Mario J.
    Choi, Doo-Sup
    BEHAVIOURAL BRAIN RESEARCH, 2016, 305 : 8 - 17
  • [7] THE EFFECTS OF NEUROTENSIN AND [D-TYR11]-NT ON THE HYPERACTIVITY INDUCED BY INTRA-ACCUMBENS ADMINISTRATION OF A POTENT DOPAMINE RECEPTOR AGONIST
    JOLICOEUR, FB
    RIVEST, R
    STPIERRE, S
    GAGNE, MA
    DUMAIS, M
    NEUROPEPTIDES, 1985, 6 (02) : 143 - 156
  • [8] NEUROCHEMICAL AND BEHAVIORAL EVIDENCE FOR A SELECTIVE PRESYNAPTIC DOPAMINE RECEPTOR AGONIST
    GOODALE, DB
    RUSTERHOLZ, DB
    LONG, JP
    FLYNN, JR
    WALSH, B
    CANNON, JG
    LEE, T
    SCIENCE, 1980, 210 (4474) : 1141 - 1143
  • [9] Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease
    Bodick, NC
    Offen, WW
    Levey, AI
    Cutler, NR
    Gauthier, SG
    Satlin, A
    Shannon, HE
    Tollefson, GD
    Rasmussen, K
    Bymaster, FP
    Hurley, DJ
    Potter, WZ
    Paul, SM
    ARCHIVES OF NEUROLOGY, 1997, 54 (04) : 465 - 473
  • [10] Exposure to the selective κ-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats
    Chartoff, Elena H.
    Potter, David
    Damez-Werno, Diane
    Cohen, Bruce M.
    Carlezon, William A., Jr.
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (11) : 2676 - 2687
12345